Skip to content
Clinical Trials – home

Metolazone: A Comprehensive Guide for Patients

2 / 2
trials open to patients / all trials
2+
Countries

In short

This article explores the use of metolazone in clinical trials for treating various conditions, primarily focusing on heart failure and kidney disease. Metolazone is a thiazide-type diuretic that has shown promise in managing fluid overload and diuretic resistance. The trials discussed here aim to evaluate the efficacy, safety, and optimal administration strategies of metolazone when used alone or in combination with other diuretics.

At a glance

Primary Conditions Studied
Acute Decompensated Heart Failure, Chronic Kidney Disease, Diuretic Resistance
Main Objectives
Evaluate efficacy and safety of metolazone in fluid management, Compare metolazone to other diuretic strategies
Key Outcome Measures
Urine output, Weight change, Serum creatinine levels, Symptom improvement (e.g., dyspnea)
Common Dosing Strategies
5-10 mg daily, often combined with loop diuretics
Safety Monitoring
Electrolyte levels, Kidney function, Blood pressure, Adverse events
Comparative Treatments
Loop diuretics (e.g., furosemide), Tolvaptan, Acetazolamide, Placebo
Trial Designs
Randomized controlled trials, Double-blind studies, Crossover designs
Patient Populations
Hospitalized heart failure patients, Chronic kidney disease patients, Patients with diuretic resistance

What is Metolazone?

Metolazone is a medication that belongs to a class of drugs called thiazide-type diuretics. It is also known by the brand name Zaroxolyn. Diuretics are commonly referred to as "water pills" because they help your body get rid of excess fluid and salt through increased urination.

What Conditions Does Metolazone Treat?

Metolazone is primarily used to treat the following conditions:

  • Acute Decompensated Heart Failure: This is a sudden worsening of heart failure symptoms, often requiring hospitalization. Metolazone helps reduce fluid buildup in the body, which is a common problem in heart failure.
  • Chronic Heart Failure: Metolazone is used in the long-term management of heart failure to help control fluid retention.
  • Chronic Kidney Disease: In some cases, metolazone is used to help manage fluid buildup in patients with kidney problems.

How Does Metolazone Work?

Metolazone works by blocking the reabsorption of salt and water in a specific part of the kidney called the distal convoluted tubule. This action increases the amount of urine produced, helping to remove excess fluid from the body. In heart failure, this can help reduce symptoms like swelling and shortness of breath.

Metolazone is often used in combination with other diuretics, particularly loop diuretics like furosemide (Lasix). This combination, known as "sequential nephron blockade," can be more effective in removing fluid than using a single diuretic alone, especially in patients who have become resistant to loop diuretics.

How is Metolazone Used in Clinical Trials?

Several clinical trials are investigating different aspects of metolazone use:

  • As an early add-on therapy for acute decompensated heart failure
  • In combination with loop diuretics for patients with diuretic resistance
  • Comparing its effectiveness to other diuretics like chlorothiazide
  • Studying its effects in patients with chronic kidney disease

Effectiveness of Metolazone

Clinical trials are evaluating the effectiveness of metolazone by measuring various outcomes, including:

  • Total urine output and negative fluid balance: This measures how much fluid is removed from the body.
  • Change in weight: Weight loss can indicate successful fluid removal.
  • Improvement in symptoms: Researchers assess whether patients feel less short of breath or have less swelling.
  • Changes in kidney function and blood tests: This helps monitor the safety and effectiveness of the treatment.

Potential Side Effects and Safety Concerns

While metolazone can be effective, it's important to be aware of potential side effects and safety concerns:

  • Electrolyte imbalances: Metolazone can cause low levels of potassium, sodium, and magnesium in the blood. These imbalances can lead to symptoms like weakness, confusion, or irregular heartbeats.
  • Kidney function changes: In some cases, metolazone can affect kidney function. Doctors monitor this closely during treatment.
  • Low blood pressure: Metolazone can sometimes cause blood pressure to drop too low, leading to dizziness or fainting.
  • Dehydration: If too much fluid is removed too quickly, it can lead to dehydration.

Comparison with Other Medications

Several clinical trials are comparing metolazone to other diuretics or treatment strategies:

  • Metolazone vs. Chlorothiazide: Some studies are comparing the effectiveness and safety of oral metolazone to intravenous chlorothiazide in patients with acute heart failure.
  • Metolazone vs. Tolvaptan: Researchers are investigating how metolazone compares to tolvaptan, a newer type of diuretic, in treating diuretic-resistant heart failure.
  • Metolazone vs. Acetazolamide: Some trials are looking at the effectiveness of metolazone compared to acetazolamide when combined with loop diuretics.

These comparisons help doctors understand which treatments might work best for different patients and in different situations.

Questions people often ask

Conditions where Metolazone is being studied

Each condition opens its own overview and trial list

Trials with Metolazone

Recruiting trials first

See all 2 →
Quick filters
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.